This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Zhu, B.-q. Articles by Karliner, J. S. Search for Related Content PubMed PubMed Citation Articles by Zhu, B.-q. Articles by Karliner, J. S. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Medline Plus Health Information Cardiomyopathy Heart Attack Hazardous Substances DB MALONALDEHYDE METOPROLOL Social Bookmarking                         What's this?

Comparison of Pyrroloquinoline Quinone and/or Metoprolol on Myocardial Infarct Size and Mitochondrial Damage in a Rat Model of Ischemia/Reperfusion Injury

Cardiology Section, VA Medical Center, Department of Medicine, University of California, San Francisco

Ursula Simonis, PhD

Department of Chemistry and Biochemistry, San Francisco State University, San Francisco, California

Gary Cecchini, PhD

Molecular Biology Division, VA Medical Center, Department of Biochemistry and Biophysics, University of California, San Francisco

Hui-zhong Zhou, MD

Cardiology Section, VA Medical Center, Department of Medicine, University of California, San Francisco

Luyi Li, MD

Cardiology Section, VA Medical Center, University of California, San Francisco

John R. Teerlink, MD, FACC

Cardiology Section, VA Medical Center, Department of Medicine, University of California, San Francisco

Joel S. Karliner, MD, FACC

Cardiology Section, VA Medical Center, Department of Medicine, Cardiovascular Research Institute, University of California, San Francisco, joel.karliner{at}med.va.gov

The cardioprotective effectiveness of low-dose pyrroloquinoline quinone (PQQ, 3 mg/kg) was compared with metoprolol, a ß₁-selective adrenoceptor antagonist. Rats underwent 30 minutes of left anterior descending coronary artery occlusion and 2 hours of reperfusion. Metoprolol and/or PQQ were given at the onset of reperfusion to mimic clinical treatment. Metoprolol and/or PQQ reduced infarct size and protected against ischemia-induced left ventricular dysfunction after 2 hours of reper-fusion. Combined therapy augmented left ventricular developed pressure at the end of reperfusion. Metoprolol or PQQ alone enhanced mitochondrial respiratory ratios in ischemic and nonischemic myocardium. Although the PQQ/metoprolol combination therapy increased respiratory ratio values, the effects were small when compared with PQQ alone. Only PQQ decreased lipid peroxidation. Metoprolol and/or PQQ given at the onset of reperfusion reduce infarct size and improve cardiac function. Combination therapy further reduces infarct size. PQQ is superior to metoprolol in protecting mitochondria from ischemia/reperfusion oxidative damage

Key Words: pyrroloquinoline quinone • metoprolol • ischemia/reperfusion

Journal of Cardiovascular Pharmacology and Therapeutics, Vol. 11, No. 2, 119-128 (2006)
DOI: 10.1177/1074248406288757


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?